유리체강내 베바시주맙 주입술을 이용한 당뇨병유두병증의 치료 1예

• 영문명: Intravitreal Bevacizumab Injection in Diabetic Papillopathy
• 발행기관: 대한안과학회
• 저자명: 신진희 최경식,Jin Hee Shin, MD, Kyung Seek Choi, MD
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume54,number8, 1298~1302쪽, 전체 5쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2013.08.15

영문 초록

Purpose: To report a case where intravitreal bevacizumab injection was an effective treatment for diabetic papillopathy in a type 2 diabetic patient. Case summary: A 47-year-old male with a 10-year history of diabetes mellitus type 2 presented to our clinic for evaluation of diabetic retinopathy. There were no subjective symptoms including blurred vision or visual defect, and best corrected visual acuity (BCVA) was 20/20 in the right eye and 20/30 in the left eye. Fundus examination showed hyperemic optic disc swelling with telangiectatic new vessels, and fluorescein angiography leakage from the optic disc with neovascularization. The patient underwent fractionated panretinal photocoagulation. Ten days later, he complained of painless blurred vision with significant optic nerve head swelling and BCVA was 20/80 in the left eye. Intravitreal bevacizumab injection was administered, optic disc swelling was significantly decreased and BCVA improved to 20/30 after two months. Conclusions: Diabetic papillopathy with severe decreased visual acuity can be treated with intravitreal bevacizumab injection.

키워드

Bevacizumab injection, Diabetic papillopathy